NCT04174976

Brief Summary

Mesh infection is the main complication in abdominal hernia repair. In case of infection, a conservative management of mesh is not always possible. The removal of the mesh (occurring in 5.1% to 8% of wall hernia repair) increases the risk of recurrence and surgical morbidity. Within our digestive surgery department (CHRU de Nancy), an infection rate of 10.7% (32 cases out of 298 patients with wall hernia repair) was observed between January 2016 and December 2018. This rate is higher than those usually described in the literature. Several studies have identified predictors of mesh infection and explantation after abdominal wall hernia repair. The influence of the operating environment (temperature, hygrometry, pressure, number of people present, etc.) has, to our knowledge, never been studied. If the risk of prosthesis infection is influenced by one or more of these extrinsic characteristics, it is possible to act on these practices to reduce this risk. The main purpose of this study is to identify the characteristics specific to the intervention and the operating environment associated with mesh infection after abdominal wall hernia reconstruction

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 28, 2017

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 21, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 22, 2019

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2021

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2022

Completed
Last Updated

December 12, 2019

Status Verified

October 1, 2019

Enrollment Period

3 years

First QC Date

November 21, 2019

Last Update Submit

December 10, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with surgical site infection

    patient has at least one of the following: purulent drainage from the deep incision. a deep incision that spontaneously dehisces, or is deliberately opened or aspirated by a surgeon, physician\* or physician designee AND organism(s) identified from the deep soft tissues of the incision by a culture or non-culture based microbiologic testing method which is performed for purposes of clinical diagnosis or treatment (for example, not Active Surveillance Culture/Testing (ASC/AST)) or culture or non-culture based microbiologic testing method is not performed. A culture or non-culture based test from the deep soft tissues of the incision that has a negative finding does not meet this criterion. AND patient has at least one of the following signs or symptoms: fever (\>38°C); localized pain or tenderness. an abscess or other evidence of infection involving the deep incision that is detected on gross anatomical or histopathologic exam, or imaging test.

    up to 1 year

Secondary Outcomes (1)

  • Number of participants with surgery for mesh explantation

    up to 1 year

Study Arms (1)

Wall hernia repair

All patients admitted for wall hernia repair with mesh between 28/12/2017 and 28/12/2020. .

Procedure: wall hernia repair

Interventions

Wall hernia repair with mesh

Wall hernia repair

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted for wall hernia repair with mesh between 28/12/2017 and 01/01/2021 (expected number of approximately 300 patients) for which follow-up data will be available during the first post-operative year

You may qualify if:

  • All patients admitted for wall hernia repair with mesh between 28/12/2017 and 28/12/2020

You may not qualify if:

  • Emergency surgery
  • Laparoscopic
  • Pregnancy
  • Adults under legal guardianship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Estelle Vigneron

Nancy, 54000, France

RECRUITING

MeSH Terms

Conditions

Surgical Wound Infection

Condition Hierarchy (Ancestors)

Wound InfectionInfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Estelle Vigneron

    CHU NANCY

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Estelle Vigneron

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2019

First Posted

November 22, 2019

Study Start

December 28, 2017

Primary Completion

January 1, 2021

Study Completion

January 1, 2022

Last Updated

December 12, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations